Dr. Scott Tebbutt is Professor in the Department of Medicine (Respiratory Division), University of British Columbia, as well as Principal Investigator and Director of Education at the Centre for Heart Lung Innovation, St. Paul’s Hospital, Vancouver, Canada. His research program is focused on the molecular and cellular understanding of complex disease and other health-related conditions, including inflammatory disorders of the lung, allergic rhinitis, heart failure, and neonatal vaccinology. Since 2009, he has been Chief Scientific Officer of the Prevention of Organ Failure (PROOF) Centre of Excellence – a not-for-profit organization dedicated to moving research findings into health care, and focused on non-invasive biomarkers that can diagnose and/or predict organ failure and other clinically-important indications. His responsibilities have included the evaluation and deployment of new, high-performance technologies to improve biomarker discovery, development and implementation, as well as bioinformatic approaches to better deal with sample heterogeneity and integration of high-dimensional ‘omic datasets. Dr. Tebbutt serves on numerous local and international scientific advisory committees, including the BC Children’s Hospital Research Institute “Transplantation and Cell Therapy (TRACE) Program Biomarker and Cell Therapy Oversight Committee (BCTOC),” the United States National Institutes of Health Human Immunology Project Consortium (HIPC) “Biostatistics and Bioinformatics Subcommittee,” and the Coalition for Epidemic Preparedness Innovations (CEPI) “Systems Immunology Task Force.” He holds a B.A. in biochemistry from the University of Oxford and a Ph.D. in molecular genetics from the University of East Anglia (Cambridge Laboratory, John Innes Centre).